aspirin has been researched along with Hepatitis C in 9 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of aspirin is a potential protective factor against the development of hepatocellular carcinoma (HCC)." | 9.22 | Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis. ( Dang, S; Liu, C; Shi, J; Wang, M; Wang, W; Wang, Y, 2022) |
| "Combining aspirin or nonsteroidal anti-inflammatory drugs with SSRIs for the treatment of interferon-associated neuropsychiatric side effects increases the risks of hemorrhage in patients with HCV who have developed cirrhosis and either portal hypertension or hepatic failure or both." | 6.20 | A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. ( Auriacombe, M; Chang, KM; Lewis, JD; Lynch, KG; Weinrieb, RM, 2003) |
| "Aspirin has been found to lower the occurrence rates of some cancers through the inhibition of the cyclooxygenase enzyme." | 5.56 | Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study. ( Hsu, CY; Hsu, RJ; Hsu, WL; Huang, SY; Liao, YH; Liu, DW; Su, YC; Wang, TH; Wu, CT, 2020) |
| "The use of aspirin is a potential protective factor against the development of hepatocellular carcinoma (HCC)." | 5.22 | Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis. ( Dang, S; Liu, C; Shi, J; Wang, M; Wang, W; Wang, Y, 2022) |
| "27 patients with histologically proven chronic active hepatitis C were divided into two groups." | 2.68 | [Treatment of chronic virus hepatitis with acetylsalicylic acid]. ( Heinrich, D; Maier, KP, 1995) |
| "Aspirin has been found to lower the occurrence rates of some cancers through the inhibition of the cyclooxygenase enzyme." | 1.56 | Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study. ( Hsu, CY; Hsu, RJ; Hsu, WL; Huang, SY; Liao, YH; Liu, DW; Su, YC; Wang, TH; Wu, CT, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Wang, M | 1 |
| Liu, C | 1 |
| Wang, W | 1 |
| Shi, J | 1 |
| Dang, S | 1 |
| Rios-Ibarra, CP | 1 |
| Verduzco-Garza, B | 1 |
| Ortiz-Lopez, R | 1 |
| Grondin, Y | 1 |
| Salinas-Santander, M | 1 |
| Arvizu-Gutierrez, LA | 1 |
| Sanchez-Salazar, MG | 1 |
| Cervantes-Astorga, E | 1 |
| Orozco-Nunnelly, DA | 1 |
| Rivas-Estilla, AM | 1 |
| Liao, YH | 1 |
| Hsu, RJ | 1 |
| Wang, TH | 1 |
| Wu, CT | 1 |
| Huang, SY | 1 |
| Hsu, CY | 1 |
| Su, YC | 1 |
| Hsu, WL | 1 |
| Liu, DW | 1 |
| Chuang, TF | 1 |
| Chen, ST | 1 |
| Wei, JC | 1 |
| Levy, IG | 1 |
| Pim, CP | 1 |
| Wong, F | 1 |
| Weinrieb, RM | 1 |
| Auriacombe, M | 1 |
| Lynch, KG | 1 |
| Chang, KM | 1 |
| Lewis, JD | 1 |
| Telman, G | 1 |
| Kouperberg, E | 1 |
| Schlesinger, I | 1 |
| Yarnitsky, D | 1 |
| Heinrich, D | 1 |
| Maier, KP | 1 |
3 reviews available for aspirin and Hepatitis C
| Article | Year |
|---|---|
Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
Topics: Aspirin; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis C; Humans; Liver Neoplasms; Risk Fa | 2022 |
Liver and kidney diseases.
Topics: Acetaminophen; Anemia, Sickle Cell; Animals; Aspirin; Cholestasis; Cysts; Glomerulonephritis, IGA; G | 2002 |
A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients.
Topics: Analgesics; Antidepressive Agents; Antiviral Agents; Aspirin; Depressive Disorder; Drug Interactions | 2003 |
2 trials available for aspirin and Hepatitis C
| Article | Year |
|---|---|
A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients.
Topics: Analgesics; Antidepressive Agents; Antiviral Agents; Aspirin; Depressive Disorder; Drug Interactions | 2003 |
[Treatment of chronic virus hepatitis with acetylsalicylic acid].
Topics: Adult; Aspirin; Female; Hepatitis C; Hepatitis, Chronic; Humans; Male; Middle Aged | 1995 |
5 other studies available for aspirin and Hepatitis C
| Article | Year |
|---|---|
Transcriptional Profile of HCV Replicon Cells after Treatment with Acetylsalicylic Acid.
Topics: Antioxidants; Antiviral Agents; Aspirin; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Replicon | 2022 |
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carcinoma, Hepatocellular; Cyclooxygenase Inhibitors; Femal | 2020 |
Daily Aspirin Therapy Reduces the Risk of Hepatocellular Carcinoma on Chronic HCV Hepatitis.
Topics: Aspirin; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Liver Neop | 2021 |
An aspirin a day: the allure (and distraction) of chemoprevention.
Topics: Alcohol Drinking; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin | 2012 |
Cessation of microemboli in the middle cerebral artery after a single dose of aspirin in a young patient with emboliogenic lacunar syndrome of carotid origin.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Brain Infar | 2006 |